Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate The Cigna Group before investing.

In this article, we go over a few key elements for understanding The Cigna Group’s stock price such as:

• The Cigna Group’s current stock price and volume
• Why The Cigna Group’s stock price changed recently
• Upgrades and downgrades for CI from analysts
• CI’s stock price momentum as measured by its relative strength

About The Cigna Group (CI)

Before we jump into The Cigna Group’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Want to learn more about The Cigna Group’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about The Cigna Group.

The Cigna Group’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, The Cigna Group’s stock price was $279.050.

The Cigna Group is down 2.99% from its previous closing price of $287.660.

During the last market session, The Cigna Group’s stock traded between $278.970 and $287.350. Currently, there are approximately 262.99 million shares outstanding for The Cigna Group.

The Cigna Group’s price-earnings (P/E) ratio is currently at 11.5, which is low compared to the Health Care Providers & Services industry median of 26.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

The Cigna Group Stock Price History

The Cigna Group’s (CI) price is currently up 1.22% so far this month.

During the month of July, The Cigna Group’s stock price has reached a high of $305.440 and a low of $273.660.

Over the last year, The Cigna Group has hit prices as high as $315.470 and as low as $239.510. Year to date, The Cigna Group’s stock is up 1.39%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused The Cigna Group Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded The Cigna Group’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate The Cigna Group’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on The Cigna Group’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

The Cigna Group’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about The Cigna Group (CI) by visiting AAII Stock Evaluator.

Relative Price Strength of The Cigna Group

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, The Cigna Group has a weighted four-quarter relative price strength of -3.33%, which translates to a Momentum Score of 41 and is considered to be Average.

Want to learn more about how The Cigna Group is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

The Cigna Group Stock Price: Bottom Line

As of July 31, 2026, The Cigna Group’s stock price is $279.050, which is down 2.99% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like The Cigna Group stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.